Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative β1-selective adrenoceptor radioligand
✍ Scribed by Dmitri V. Soloviev; Mario Matarrese; Rosa Maria Moresco; Sergio Todde; Thomas A. Bonasera; Francesco Sudati; Pasquale Simonelli; Fulvio Magni; Diego Colombo; Assunta Carpinelli; Marzia Galli Kienle; Ferruccio Fazio
- Book ID
- 117409559
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 327 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0197-0186
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract __Introduction:__ (__R__)‐3‐(2‐(methylthio)phenoxy)‐__N__‐methyl‐3‐phenylpropan‐1‐amine [(__R__)–thionisoxetine; **1**] is a potent inhibitor of the norepinephrine transporter (NET). We aimed to label **1** with carbon‐11 (__t__~1/2~ = 20.4 min) for evaluation as a radioligand for imagi
## Abstract Carbon‐11 labeled (__R__)‐(−)‐Deprenyl is the tracer of reference for the quantification of monoamine oxidase (MAO)‐B activity with PET. In this paper, its radiosynthesis is re‐investigated and oriented towards the preparation of multi‐milliCuries of radiotracer. Typically, using no‐car
Molecular imaging and quantification of myocardial b 1 -adrenoceptor (AR) rather than total b-AR density is of great clinical interest since cardiac biopsy studies suggest that myocardial b 1 -AR density is reduced in patients with chronic heart failure whereas cardiac b 2 -AR density may vary. Posi
Racemic 1- [3-(5-methoxy-1,2,3,4-tetrahydro-1-naphtalenyl)propyl]-4-phenylpiperazine (PNU-157760) was labeled with carbon-11 (t 1/2 ϭ 20.4 min) as a putative radioligand for the noninvasive assessment of 5-HT 1A receptors in vivo with positron emission tomography (PET). The radiochemical synthesis c